519-41-5 (2,6-DIHYDROXY-3,7-DIMETHYLPURINE,2,6-DIHYDROXY-3,7-DIMETHYLPURINE)

2,6-DIHYDROXY-3,7-DIMETHYLPURINE;3,7-dimethylpurine-2,6-dione,2-hydroxybenzoic acid;THEOBROMINE;BPBio1_001043;BBL034679;Theobrominum;CCG-40078;KBio3_001258;SDCCGSBI-0051154.P004;HMS501O13;201-494-2;EINECS 201-494-2;THEOBROMINE [EP IMPURITY];Theobromine (Standard);3,7-Dimethyl-xanthine;NCGC00016023-10;C07480;NCGC00016023-08;DA-68137;SY048379;SC-15090;NINDS_000611;NCGC00261872-01;Q206844;SDCCGMLS-0002875.P003;KBioSS_000433;1H-purine-2,6-dione,3,7-dihydro-3,7- dimethyl- (9CI);37T;HMS2092G04;WLN: T56 BN DN FNVMVJ B1 F1;Theobromine, >=98.0%;NCGC00016023-01;EN300-16609;DTXSID9026132;DB01412;BSPBio_000947;THEOBROMINE [VANDF];HMS2097P09;NCGC00016023-15;STL419465;SR-01000000069;THEOBROMINE [MI];Lopac0_001187;KBio2_005569;Z56347209;Thesal;SR-01000000069-7;3,7-Dimethyl-3,7-dihydro-1H-purine-2,6-dione #;Tox21_300016;Theostene;s2368;SR-01000000069-10;3,7-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione;SPBio_001049;LP01187;NCGC00179030-02;THEOBROMINE [MART.];T0178;purine-2,6(1H,3H)-dione, 3,7-dimethyl-;InChI=1/C7H8N4O2/c1-10-3-8-5-4(10)6(12)9-7(13)11(5)2/h3H,1-2H3,(H,9,12,13);HSDB 7332;SC 15090;NCGC00016023-18;BRD-K34888156-001-11-2;3,7-DIMETHYLXANTHINE; 3,7-DIMETHYLPURINE-2,6-DIONE;EU-0101187;IDI1_000611;HMS3714P09;AC-34381;NCGC00024123-05;PDSP1_001017;1H-Purine-2, 3,7-dihydro-3,7-dimethyl-;Theobromine, analytical standard;NCGC00024123-08;SBI-0051154.P003;Theosalvose;CAS-83-67-0;CCRIS 2350;NCGC00253943-01;AKOS000121558;Spectrum3_000279;Teobromin;YAPQBXQYLJRXSA-UHFFFAOYSA-;Xantheose;Theobromine(20%);NCGC00016023-03;SPBio_002868;NSC757407;3,7-Dimethyl-1H-purine-2,6(3H,7H)-dione;Theobromin;NCGC00024123-03;Theobromine, European Pharmacopoeia (EP) Reference Standard;Spectrum4_000403;5-26-13-00553 (Beilstein Handbook Reference);KBio2_003001;3,7-dimethylpurine-2,6-dione;Xanthine, 3,7-dimethyl-;HMS3263N15;NCGC00024123-04;HY-N0138;BDBM50014260;NCGC00016023-09;HY-N0138R;Theobromine, Pharmaceutical Secondary Standard; Certified Reference Material;NCGC00016023-05;Santheose;3,7-dimethylxanthin;NCGC00016023-17;NCGC00016023-12;519-41-5;BRN 0016464;Tox21_110284_1;BRD-K34888156-001-08-8;Tox21_110284;FEMA No. 3591;PENTOXIFYLLINE IMPURITY A [EP IMPURITY];FT33795;HMS1921O13;NCGC00016023-13;SR-01000000069-8;DTXCID506132;Spectrum5_001387;THEOBROMINUM [HPUS];Caffeine EP impurity D;THEOBROMINE (EP IMPURITY);5-26-13-00553 (Beilstein);HMS1570P09;Theobromine (natural);SMR000058357;3,7-Dimethylxanthine;UNII-OBD445WZ5P;THEOBROMINE [IARC];2,6-Dihydroxy-3,7-dimethyl-purine;SCHEMBL3184;Theobromine, >=98.0% (HPLC);Prestwick3_000874;SR-01000000069-4;1H-Purine-2,6-dione, 3,7-dihydro-3,7-dimethyl-;Thesodate;THEOBROMINE [WHO-DD];AS-13904;AB00052141_12;T 4500;NSC-5039;NCGC00016023-02;NCGC00016023-26;3,7-dimethyl-1H-purine-2,6-dione;Pharmakon1600-01500649;Spectrum2_000985;NSC-757407;KBioGR_000666;DivK1c_000611;CHEMBL1114;NSC 5039;NCGC00016023-04;THEOBROMINE [HSDB];Theobromine (3,7-Dimethylxanthine);Prestwick0_000874;CS-7972;KBio1_000611;SR-01000000069-9;NCGC00016023-14;NCGC00024123-07;BRD-K34888156-213-01-4;NSC5039;7-Dimethylxanthine;MLS000028407;NCGC00179030-01;AB00052141;NCGC00016023-06;OBD445WZ5P;Spectrum_000053;MFCD00022830;CHEBI:28946;Prestwick_1054;Theobromine 0.1 mg/ml in Methanol;D71206;NCGC00016023-07;NCGC00024123-06;KBio2_000433;AC-11381;CAFFEINE MONOHYDRATE IMPURITY D [EP IMPURITY];Prestwick1_000874;Prestwick2_000874;THEOBROMINE (MART.);3,7-Dihydro-3,7-dimethyl-1H-purine-2,6-dione;PENTOXIFYLLINE IMPURITY A (EP IMPURITY);Theobromine [INN:BAN:NF];CEC63CCA-3B4B-4F4F-92C1-1789DF3C880A;83-67-0;Lopac-T-4500;3,7-dimethyl-1,3,7-trihydropurine-2,6-dione;Diurobromine;3,7-Dimethyl-3,7-dihydro-1H-purine-2,6-dione;THEOBROMINE (IARC);SPECTRUM1500649;THEOBROMINE [FHFI];NS00009946;Tox21_501187;BSPBio_001758;SR-01000000069-2;NCGC00016023-11;PDSP2_001001;

YAPQBXQYLJRXSA-UHFFFAOYSA-N

1S/C7H8N4O2/c1-10-3-8-5-4(10)6(12)9-7(13)11(5)2/h3H,1-2H3,(H,9,12,13)

O=C1C2=C(N=CN2C)N(C)C(N1)=O